Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells

Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis

(2011) Kirk Jensen et al.   ENDOCRINE-RELATED CANCER

Mammalian Target of Rapamycin Pathway Activation Is Associated to RET Mutation Status in Medullary Thyroid Carcinoma

(2011) Ida Rapa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena

(2010) Begoña Martin-Castillo et al.   CELL CYCLE

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

(2010) Zhijun Luo et al.   Future Oncology

Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience

(2010) Maria E. Cabanillas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

(2010) Elaine T. Lam et al.   JOURNAL OF CLINICAL ONCOLOGY

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

(2010) I. Ben Sahra et al.   MOLECULAR CANCER THERAPEUTICS

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

(2009) R. J. Shaw   Acta Physiologica

Acute Metformin Overdose: Examining Serum pH, Lactate Level, and Metformin Concentrations in Survivors Versus Nonsurvivors: A Systematic Review of the Literature

(2009) Damon M. Dell'Aglio et al.   ANNALS OF EMERGENCY MEDICINE

KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity

(2009) Diane L. Costanzo-Garvey et al.   Cell Metabolism

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt–mTOR–p70S6K pathway in human medullary thyroid carcinoma cells

(2009) Simona Grozinsky-Glasberg et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Targeting RET for thyroid cancer therapy

(2008) Cinzia Lanzi et al.   BIOCHEMICAL PHARMACOLOGY

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer

(2008) Walter H. Gotlieb et al.   GYNECOLOGIC ONCOLOGY

Active N-Ras and B-Raf Inhibit Anoikis by Downregulating Bim Expression in Melanocytic Cells

(2008) Nathaniel B. Goldstein et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE